SPSeeta Ramaraju Pericherla

Seeta Ramaraju Pericherla

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seeta Ramaraju Pericherla has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gene2Phenotype: A Database of Structured Human Monogenic Diseases and Pathomechanisms

    by Sarah E. Hunt, Diana Lemos, Seeta Ramaraju Pericherla, Olanrewaju Austine-Orimoloye, Elena Cibrian Uhalte, T. Michael Yates, Morad Ansari, Louise Thompson, Julia Foreman, T. Ian Simpson, et al.


  • Open Access

    A Blueprint for Open Science: How Transatlantic Teams Built and Deployed Knowledge Graphs to Enable Biological (AI) Models

    by Mina P. Peyton, Cheng-Han Chung, Samarpan Mohanty, Van Q. Truong, Andrew Scouten, Sangeeta Shukla, Chantera Lazard, Daniall Masood, John D. Murphy, Anne Ketter, et al.

    Knowledge graphs (KGs) and large language models (LLMs) are increasingly applied in biomedical research; however, LLMs' tendency to hallucinate and lack of evidence traceability poses significant challenges for rigorous scientific applications. To address these limitations, the NVIDIA - AWS Open Data Knowledge Graph Hackathon, which brought together transatlantic teams, catalyzed the development of novel frameworks that built or integrated KGs with graph-based retrieval-augmented generation (GraphRAG) to enhance evidence-grounded generative AI. The hackathon took place on October 1-3, 2025, at two locations - the AWS Skills Center in Arlington, VA, USA and the European Bioinformatics Institute (EBI) Training Center in Cambridge, UK. Across seven prototype projects, participating teams developed systems that construct, validate, and deploy biomedical KGs using open data and cloud-native infrastructure. These included GeNETwork, which integrates pediatric oncology datasets to identify therapeutic targets; ECoGraph, a multi-omics graph framework for characterizing colorectal cancer drivers; ClassiGraph, a graph neural network classifier for cancer subtypes; EasyGiraffe, a validator for multisite polygenicity extraction; MIDAS (Model Integration and Data Assembly System), a pipeline for harmonizing heterogeneous biomedical datasets; KG Model Garbage Collection, a framework for detecting and pruning erroneous AI-generated edges; and BioGraphRAG, which combines precision medicine and literature-derived KGs for evidence-based question answering. Together, these prototypes demonstrate practical strategies for constructing and deploying biomedical KGs and highlight the potential of GraphRAG to produce interpretable, verifiable AI-driven insights. By emphasizing open data, reproducible pipelines, and evidence-grounded reasoning, this work advances methodologies for trustworthy generative AI in biomedical discovery.


  • Open Access

    Domain-wide Mapping of Peer-reviewed Literature for Genetic Developmental Disorders using Machine Learning and Gene2Phenotype

    by Thabo Michael Yates, Sarah E. Hunt, Diana Lemos, Seeta Ramaraju Pericherla, Elena Cibrian Uhalte, Morad Ansari, Louise Thompson, Simona E. Doneva, Caroline F. Wright, Helen V. Firth, et al.

    Genetically determined developmental disorders (GDD) are rare, heterogeneous conditions for which clinical diagnosis increasingly depends on genomic variant prioritisation and rapid synthesis of genotype–phenotype evidence scattered across the literature. Manual curation of this evidence is labour-intensive, difficult to scale and to keep up to date. We present a domain-wide, automated pipeline that identifies PubMed abstracts describing human case reports/series and maps them to molecularly defined diseases in the Gene2Phenotype database (G2P). The natural language processing system combines a fine-tuned BERT classifier (LitDD BERT) to detect GDD-relevant abstracts, a fine-tuned cross-encoder (LitDD Crossencoder) to propose disease candidates, and a constrained large language model to adjudicate final mappings. Trained on 13,738 annotated title–abstract pairs spanning 231 genes and 354 G2P entries, LitDD BERT achieved an F1 of 0.89 (precision 0.83, recall 0.94). The cross-encoder reached 0.99 top-5 recall, and the full ensemble attained precision 0.89, recall 0.82, and F1 0.85 on a held-out test set. Applied to the entirety of PubMed, the pipeline identified approximately 69,000 manuscripts which could be mapped to G2P diseases. Against independent manually curated sets, it retrieved about 70% of manuscripts at both micro and macro levels, indicating generalization across diverse disease mechanisms, differing curation standards and inheritance patterns. The resulting corpus is accessible through G2P and is being integrated into routine biocuration. This work delivers scalable, updateable literature surveillance for GDD, enabling faster evidence review in a diagnostic setting, supporting bioinformatic pipelines, and laying a foundation for downstream case-level extraction and standardized phenotype integration.